APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologics Development Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biologics Development Service Market Outlook and Growth Opportunities 2026

2 May 2026193 pages

Choose your research edition.

Industry ResearchBiologics Development Service Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologics Development Service Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biologics Development Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologics Development Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologics Development Service Market Analysis and Forecast 2026-2032249 pages · $4,950 USD

Market perspective

The global Biologics Development Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biologics Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biologics Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologics Development Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biologics Development Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biologics Development Service market include Meso Scale Discovery, Patheon, Immunologix, GenScript, Promega, Recibiopharm, Alcami Biologics, Leadgene Biomedical and Samsung Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Biologics Development Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biologics Development Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biologics Development Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biologics Development Service market.

Biologics Development Service Segment by Company

Meso Scale Discovery

Patheon

Immunologix

GenScript

Promega

Recibiopharm

Alcami Biologics

Leadgene Biomedical

Samsung Biologics

Lonza

ImmunoGen

Seattle Genetics

Roche

Takeda

Biologics Development Service Segment by Type

Vaccine

Blood and Blood Components

Tissue and Recombinant Therapeutic Proteins

Others

Biologics Development Service Segment by Application

Tumor Treatment

Chronic Disease Treatment

Enzyme and Hormone Deficiencies

Others

Biologics Development Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biologics Development Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biologics Development Service key companies, revenue, market share, and recent developments.

3. To split the Biologics Development Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biologics Development Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biologics Development Service significant trends, drivers, influence factors in global and regions.

6. To analyze Biologics Development Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics Development Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologics Development Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics Development Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biologics Development Service industry.

Chapter 3: Detailed analysis of Biologics Development Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biologics Development Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biologics Development Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biologics Development Service Industry Trends Table 2. Biologics Development Service Industry Drivers Table 3. Biologics Development Service Industry Opportunities and Challenges Table 4. Biologics Development Service Industry Restraints Table 5. Global Biologics Development Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biologics Development Service Revenue Share by Company (2021-2026) Table 7. Global Biologics Development Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biologics Development Service Key Company Manufacturing Base & Headquarters Table 9. Global Biologics Development Service Company, Product Type & Application Table 10. Global Biologics Development Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biologics Development Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Vaccine Table 15. Significant Companies of Blood and Blood Components Table 16. Significant Companies of Tissue and Recombinant Therapeutic Proteins Table 17. Significant Companies of Others Table 18. Global Biologics Development Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Biologics Development Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Biologics Development Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Biologics Development Service Sales Value Share by Type (2021-2026) Table 22. Global Biologics Development Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Tumor Treatment Table 24. Significant Companies of Chronic Disease Treatment Table 25. Significant Companies of Enzyme and Hormone Deficiencies Table 26. Significant Companies of Others Table 27. Global Biologics Development Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Biologics Development Service Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Biologics Development Service Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Biologics Development Service Sales Value Share by Application (2021-2026) Table 31. Global Biologics Development Service Sales Value Share by Application (2027-2032) Table 32. Global Biologics Development Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Biologics Development Service Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Biologics Development Service Sales Value Share by Region (2021-2026) Table 35. Global Biologics Development Service Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Biologics Development Service Sales Value Share by Region (2027-2032) Table 37. Global Biologics Development Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Biologics Development Service Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Biologics Development Service Sales Value Market Share by Country (2021-2026) Table 40. Global Biologics Development Service Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Biologics Development Service Sales Value Market Share by Country (2027-2032) Table 42. Meso Scale Discovery Company Information Table 43. Meso Scale Discovery Business Overview Table 44. Meso Scale Discovery Biologics Development Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Meso Scale Discovery Biologics Development Service Product Portfolio Table 46. Meso Scale Discovery Recent Development Table 47. Patheon Company Information Table 48. Patheon Business Overview Table 49. Patheon Biologics Development Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Patheon Biologics Development Service Product Portfolio Table 51. Patheon Recent Development Table 52. Immunologix Company Information Table 53. Immunologix Business Overview Table 54. Immunologix Biologics Development Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Immunologix Biologics Development Service Product Portfolio Table 56. Immunologix Recent Development Table 57. GenScript Company Information Table 58. GenScript Business Overview Table 59. GenScript Biologics Development Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. GenScript Biologics Development Service Product Portfolio Table 61. GenScript Recent Development Table 62. Promega Company Information Table 63. Promega Business Overview Table 64. Promega Biologics Development Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Promega Biologics Development Service Product Portfolio Table 66. Promega Recent Development Table 67. Recibiopharm Company Information Table 68. Recibiopharm Business Overview Table 69. Recibiopharm Biologics Development Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Recibiopharm Biologics Development Service Product Portfolio Table 71. Recibiopharm Recent Development Table 72. Alcami Biologics Company Information Table 73. Alcami Biologics Business Overview Table 74. Alcami Biologics Biologics Development Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Alcami Biologics Biologics Development Service Product Portfolio Table 76. Alcami Biologics Recent Development Table 77. Leadgene Biomedical Company Information Table 78. Leadgene Biomedical Business Overview Table 79. Leadgene Biomedical Biologics Development Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Leadgene Biomedical Biologics Development Service Product Portfolio Table 81. Leadgene Biomedical Recent Development Table 82. Samsung Biologics Company Information Table 83. Samsung Biologics Business Overview Table 84. Samsung Biologics Biologics Development Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Samsung Biologics Biologics Development Service Product Portfolio Table 86. Samsung Biologics Recent Development Table 87. Lonza Company Information Table 88. Lonza Business Overview Table 89. Lonza Biologics Development Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Lonza Biologics Development Service Product Portfolio Table 91. Lonza Recent Development Table 92. ImmunoGen Company Information Table 93. ImmunoGen Business Overview Table 94. ImmunoGen Biologics Development Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. ImmunoGen Biologics Development Service Product Portfolio Table 96. ImmunoGen Recent Development Table 97. Seattle Genetics Company Information Table 98. Seattle Genetics Business Overview Table 99. Seattle Genetics Biologics Development Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Seattle Genetics Biologics Development Service Product Portfolio Table 101. Seattle Genetics Recent Development Table 102. Roche Company Information Table 103. Roche Business Overview Table 104. Roche Biologics Development Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Roche Biologics Development Service Product Portfolio Table 106. Roche Recent Development Table 107. Takeda Company Information Table 108. Takeda Business Overview Table 109. Takeda Biologics Development Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Takeda Biologics Development Service Product Portfolio Table 111. Takeda Recent Development Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Biologics Development Service Product Image Figure 2. Global Biologics Development Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologics Development Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Biologics Development Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Vaccine Image Figure 8. Blood and Blood Components Image Figure 9. Tissue and Recombinant Therapeutic Proteins Image Figure 10. Others Image Figure 11. Global Biologics Development Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Biologics Development Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Biologics Development Service Sales Value Share by Type (2021-2032) Figure 14. Tumor Treatment Image Figure 15. Chronic Disease Treatment Image Figure 16. Enzyme and Hormone Deficiencies Image Figure 17. Others Image Figure 18. Global Biologics Development Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Biologics Development Service Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Biologics Development Service Sales Value Share by Application (2021-2032) Figure 21. Global Biologics Development Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Biologics Development Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Biologics Development Service Sales Value (2021-2032) & (US$ Million) Figure 24. North America Biologics Development Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Biologics Development Service Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Biologics Development Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Biologics Development Service Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Biologics Development Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Biologics Development Service Sales Value (2021-2032) & (US$ Million) Figure 30. South America Biologics Development Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Biologics Development Service Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Biologics Development Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Biologics Development Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Biologics Development Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Biologics Development Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Vaccine
  • Blood and Blood Components
  • Tissue and Recombinant Therapeutic Proteins
  • Others
Applications
  • Tumor Treatment
  • Chronic Disease Treatment
  • Enzyme and Hormone Deficiencies
  • Others
Companies covered
  • Meso Scale Discovery
  • Patheon
  • Immunologix
  • GenScript
  • Promega
  • Recibiopharm
  • Alcami Biologics
  • Leadgene Biomedical
  • Samsung Biologics
  • Lonza
  • ImmunoGen
  • Seattle Genetics
  • Roche
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biologics Development Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biologics Development Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biologics Development Service Market Dynamics
  1. 2.1 Biologics Development Service Industry Trends
  2. 2.2 Biologics Development Service Industry Drivers
  3. 2.3 Biologics Development Service Industry Opportunities and Challenges
  4. 2.4 Biologics Development Service Industry Restraints
3 Biologics Development Service Market by Company
  1. 3.1 Global Biologics Development Service Company Revenue Ranking in 2025
  2. 3.2 Global Biologics Development Service Revenue by Company (2021-2026)
  3. 3.3 Global Biologics Development Service Company Ranking (2024-2026)
  4. 3.4 Global Biologics Development Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Biologics Development Service Company Product Type and Application
  6. 3.6 Global Biologics Development Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biologics Development Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biologics Development Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biologics Development Service Market by Type
  1. 4.1 Biologics Development Service Type Introduction
  2. 4.1.1 Vaccine
  3. 4.1.2 Blood and Blood Components
  4. 4.1.3 Tissue and Recombinant Therapeutic Proteins
  5. 4.1.4 Others
  6. 4.2 Global Biologics Development Service Sales Value by Type
  7. 4.2.1 Global Biologics Development Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Biologics Development Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Biologics Development Service Sales Value Share by Type (2021-2032)
5 Biologics Development Service Market by Application
  1. 5.1 Biologics Development Service Application Introduction
  2. 5.1.1 Tumor Treatment
  3. 5.1.2 Chronic Disease Treatment
  4. 5.1.3 Enzyme and Hormone Deficiencies
  5. 5.1.4 Others
  6. 5.2 Global Biologics Development Service Sales Value by Application
  7. 5.2.1 Global Biologics Development Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Biologics Development Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Biologics Development Service Sales Value Share by Application (2021-2032)
6 Biologics Development Service Regional Value Analysis
  1. 6.1 Global Biologics Development Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biologics Development Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biologics Development Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biologics Development Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biologics Development Service Sales Value (2021-2032)
  7. 6.3.2 North America Biologics Development Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biologics Development Service Sales Value (2021-2032)
  10. 6.4.2 Europe Biologics Development Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biologics Development Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biologics Development Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biologics Development Service Sales Value (2021-2032)
  16. 6.6.2 South America Biologics Development Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biologics Development Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biologics Development Service Sales Value Share by Country, 2025 VS 2032
7 Biologics Development Service Country-level Value Analysis
  1. 7.1 Global Biologics Development Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biologics Development Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biologics Development Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biologics Development Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biologics Development Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biologics Development Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biologics Development Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biologics Development Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biologics Development Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biologics Development Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biologics Development Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biologics Development Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biologics Development Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biologics Development Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biologics Development Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biologics Development Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biologics Development Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biologics Development Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biologics Development Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biologics Development Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biologics Development Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biologics Development Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biologics Development Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biologics Development Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biologics Development Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biologics Development Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biologics Development Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biologics Development Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biologics Development Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biologics Development Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biologics Development Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biologics Development Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biologics Development Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biologics Development Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biologics Development Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Meso Scale Discovery
  2. 8.1.1 Meso Scale Discovery Company Information
  3. 8.1.2 Meso Scale Discovery Business Overview
  4. 8.1.3 Meso Scale Discovery Biologics Development Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Meso Scale Discovery Biologics Development Service Product Portfolio
  6. 8.1.5 Meso Scale Discovery Recent Developments
  7. 8.2 Patheon
  8. 8.2.1 Patheon Company Information
  9. 8.2.2 Patheon Business Overview
  10. 8.2.3 Patheon Biologics Development Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Patheon Biologics Development Service Product Portfolio
  12. 8.2.5 Patheon Recent Developments
  13. 8.3 Immunologix
  14. 8.3.1 Immunologix Company Information
  15. 8.3.2 Immunologix Business Overview
  16. 8.3.3 Immunologix Biologics Development Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Immunologix Biologics Development Service Product Portfolio
  18. 8.3.5 Immunologix Recent Developments
  19. 8.4 GenScript
  20. 8.4.1 GenScript Company Information
  21. 8.4.2 GenScript Business Overview
  22. 8.4.3 GenScript Biologics Development Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GenScript Biologics Development Service Product Portfolio
  24. 8.4.5 GenScript Recent Developments
  25. 8.5 Promega
  26. 8.5.1 Promega Company Information
  27. 8.5.2 Promega Business Overview
  28. 8.5.3 Promega Biologics Development Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Promega Biologics Development Service Product Portfolio
  30. 8.5.5 Promega Recent Developments
  31. 8.6 Recibiopharm
  32. 8.6.1 Recibiopharm Company Information
  33. 8.6.2 Recibiopharm Business Overview
  34. 8.6.3 Recibiopharm Biologics Development Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Recibiopharm Biologics Development Service Product Portfolio
  36. 8.6.5 Recibiopharm Recent Developments
  37. 8.7 Alcami Biologics
  38. 8.7.1 Alcami Biologics Company Information
  39. 8.7.2 Alcami Biologics Business Overview
  40. 8.7.3 Alcami Biologics Biologics Development Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Alcami Biologics Biologics Development Service Product Portfolio
  42. 8.7.5 Alcami Biologics Recent Developments
  43. 8.8 Leadgene Biomedical
  44. 8.8.1 Leadgene Biomedical Company Information
  45. 8.8.2 Leadgene Biomedical Business Overview
  46. 8.8.3 Leadgene Biomedical Biologics Development Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Leadgene Biomedical Biologics Development Service Product Portfolio
  48. 8.8.5 Leadgene Biomedical Recent Developments
  49. 8.9 Samsung Biologics
  50. 8.9.1 Samsung Biologics Company Information
  51. 8.9.2 Samsung Biologics Business Overview
  52. 8.9.3 Samsung Biologics Biologics Development Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Samsung Biologics Biologics Development Service Product Portfolio
  54. 8.9.5 Samsung Biologics Recent Developments
  55. 8.10 Lonza
  56. 8.10.1 Lonza Company Information
  57. 8.10.2 Lonza Business Overview
  58. 8.10.3 Lonza Biologics Development Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lonza Biologics Development Service Product Portfolio
  60. 8.10.5 Lonza Recent Developments
  61. 8.11 ImmunoGen
  62. 8.11.1 ImmunoGen Company Information
  63. 8.11.2 ImmunoGen Business Overview
  64. 8.11.3 ImmunoGen Biologics Development Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ImmunoGen Biologics Development Service Product Portfolio
  66. 8.11.5 ImmunoGen Recent Developments
  67. 8.12 Seattle Genetics
  68. 8.12.1 Seattle Genetics Company Information
  69. 8.12.2 Seattle Genetics Business Overview
  70. 8.12.3 Seattle Genetics Biologics Development Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Seattle Genetics Biologics Development Service Product Portfolio
  72. 8.12.5 Seattle Genetics Recent Developments
  73. 8.13 Roche
  74. 8.13.1 Roche Company Information
  75. 8.13.2 Roche Business Overview
  76. 8.13.3 Roche Biologics Development Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Roche Biologics Development Service Product Portfolio
  78. 8.13.5 Roche Recent Developments
  79. 8.14 Takeda
  80. 8.14.1 Takeda Company Information
  81. 8.14.2 Takeda Business Overview
  82. 8.14.3 Takeda Biologics Development Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Takeda Biologics Development Service Product Portfolio
  84. 8.14.5 Takeda Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst